Matthew Sykes
Stock Analyst at Goldman Sachs
(2.36)
# 1,450
Out of 4,412 analysts
147
Total ratings
43.36%
Success rate
-2.67%
Average return
Main Sectors:
27 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACB Pacific Biosciences of California | Maintains: Neutral | $7 → $2.5 | $1.47 | +70.07% | 3 | Apr 19, 2024 | |
| VCYT Veracyte | Maintains: Buy | $32 → $28 | $19.31 | +45.00% | 3 | Apr 15, 2024 | |
| NTRA Natera | Maintains: Buy | $90 → $100 | $91.66 | +9.10% | 11 | Apr 15, 2024 | |
| GH Guardant Health | Maintains: Buy | $32 → $28 | $17.35 | +61.38% | 9 | Apr 15, 2024 | |
| WGS GeneDx Holdings | Maintains: Neutral | $6 → $11 | $11.08 | -0.72% | 6 | Apr 15, 2024 | |
| TMO Thermo Fisher | Maintains: Buy | $550 → $640 | $573.60 | +11.58% | 3 | Apr 10, 2024 | |
| BRKR Bruker | Maintains: Sell | $66 → $74 | $80.97 | -8.61% | 2 | Apr 10, 2024 | |
| CTKB Cytek Biosciences | Maintains: Buy | $9 → $10 | $5.76 | +73.61% | 8 | Feb 29, 2024 | |
| NEO NeoGenomics | Maintains: Buy | $17 → $19 | $14.14 | +34.37% | 5 | Feb 22, 2024 | |
| MYGN Myriad Genetics | Maintains: Buy | $28 → $31 | $18.18 | +70.52% | 9 | Jan 30, 2024 | |
| OMIC Singular Genomics Systems | Maintains: Neutral | $0.95 → $0.85 | $0.40 | +110.29% | 9 | Jan 23, 2024 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $1.25 → $1.1 | $0.86 | +27.89% | 5 | Jan 23, 2024 | |
| TWST Twist Bioscience | Maintains: Buy | $25 → $45 | $31.54 | +42.68% | 8 | Jan 18, 2024 | |
| AVTR Avantor | Maintains: Buy | $23 → $26 | $23.94 | +8.60% | 4 | Dec 7, 2023 | |
| A Agilent Technologies | Maintains: Buy | $128 → $145 | $137.74 | +5.27% | 4 | Dec 7, 2023 | |
| DHR Danaher | Downgrades: Neutral | n/a | $246.58 | - | 3 | Dec 7, 2023 | |
| QGEN Qiagen | Upgrades: Buy | n/a | $41.65 | - | 4 | Dec 7, 2023 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,185 → $1,030 | $1,238.09 | -16.81% | 4 | Nov 13, 2023 | |
| HLTH Cue Health | Maintains: Neutral | $0.75 → $0.5 | $0.14 | +254.61% | 6 | Nov 10, 2023 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $7 | $7.70 | -9.09% | 6 | Nov 9, 2023 | |
| EXAS Exact Sciences | Maintains: Buy | $100 → $90 | $58.85 | +52.93% | 5 | Nov 3, 2023 | |
| RVTY Revvity | Maintains: Buy | $120 → $105 | $101.51 | +3.44% | 1 | Oct 31, 2023 | |
| QTRX Quanterix | Maintains: Buy | $30 → $34 | $15.56 | +118.51% | 12 | Sep 28, 2023 | |
| TXG 10x Genomics | Maintains: Sell | $25 → $30 | $27.59 | +8.74% | 3 | Jul 13, 2023 | |
| CDNA CareDx | Maintains: Buy | $25 → $13 | $7.56 | +71.96% | 5 | Mar 7, 2023 | |
| OLK Olink Holding AB (publ) | Maintains: Neutral | $16 → $18 | $22.84 | -21.19% | 5 | Feb 23, 2023 | |
| NAUT Nautilus Biotechnology | Maintains: Neutral | $4 → $2 | $2.49 | -19.68% | 4 | Aug 3, 2022 |
Pacific Biosciences of California
Apr 19, 2024
Maintains: Neutral
Price Target: $7 → $2.5
Current: $1.47
Upside: +70.07%
Veracyte
Apr 15, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $19.31
Upside: +45.00%
Natera
Apr 15, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $91.66
Upside: +9.10%
Guardant Health
Apr 15, 2024
Maintains: Buy
Price Target: $32 → $28
Current: $17.35
Upside: +61.38%
GeneDx Holdings
Apr 15, 2024
Maintains: Neutral
Price Target: $6 → $11
Current: $11.08
Upside: -0.72%
Thermo Fisher
Apr 10, 2024
Maintains: Buy
Price Target: $550 → $640
Current: $573.60
Upside: +11.58%
Bruker
Apr 10, 2024
Maintains: Sell
Price Target: $66 → $74
Current: $80.97
Upside: -8.61%
Cytek Biosciences
Feb 29, 2024
Maintains: Buy
Price Target: $9 → $10
Current: $5.76
Upside: +73.61%
NeoGenomics
Feb 22, 2024
Maintains: Buy
Price Target: $17 → $19
Current: $14.14
Upside: +34.37%
Myriad Genetics
Jan 30, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $18.18
Upside: +70.52%
Singular Genomics Systems
Jan 23, 2024
Maintains: Neutral
Price Target: $0.95 → $0.85
Current: $0.40
Upside: +110.29%
Ginkgo Bioworks Holdings
Jan 23, 2024
Maintains: Sell
Price Target: $1.25 → $1.1
Current: $0.86
Upside: +27.89%
Twist Bioscience
Jan 18, 2024
Maintains: Buy
Price Target: $25 → $45
Current: $31.54
Upside: +42.68%
Avantor
Dec 7, 2023
Maintains: Buy
Price Target: $23 → $26
Current: $23.94
Upside: +8.60%
Agilent Technologies
Dec 7, 2023
Maintains: Buy
Price Target: $128 → $145
Current: $137.74
Upside: +5.27%
Danaher
Dec 7, 2023
Downgrades: Neutral
Price Target: n/a
Current: $246.58
Upside: -
Qiagen
Dec 7, 2023
Upgrades: Buy
Price Target: n/a
Current: $41.65
Upside: -
Mettler-Toledo International
Nov 13, 2023
Maintains: Neutral
Price Target: $1,185 → $1,030
Current: $1,238.09
Upside: -16.81%
Cue Health
Nov 10, 2023
Maintains: Neutral
Price Target: $0.75 → $0.5
Current: $0.14
Upside: +254.61%
Maravai LifeSciences Holdings
Nov 9, 2023
Maintains: Neutral
Price Target: $8 → $7
Current: $7.70
Upside: -9.09%
Exact Sciences
Nov 3, 2023
Maintains: Buy
Price Target: $100 → $90
Current: $58.85
Upside: +52.93%
Revvity
Oct 31, 2023
Maintains: Buy
Price Target: $120 → $105
Current: $101.51
Upside: +3.44%
Quanterix
Sep 28, 2023
Maintains: Buy
Price Target: $30 → $34
Current: $15.56
Upside: +118.51%
10x Genomics
Jul 13, 2023
Maintains: Sell
Price Target: $25 → $30
Current: $27.59
Upside: +8.74%
CareDx
Mar 7, 2023
Maintains: Buy
Price Target: $25 → $13
Current: $7.56
Upside: +71.96%
Olink Holding AB (publ)
Feb 23, 2023
Maintains: Neutral
Price Target: $16 → $18
Current: $22.84
Upside: -21.19%
Nautilus Biotechnology
Aug 3, 2022
Maintains: Neutral
Price Target: $4 → $2
Current: $2.49
Upside: -19.68%